Company Information
CIN
Status
Date of Incorporation
31 December 1979
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
18 July 2023
Paid Up Capital
256,250,310
Authorised Capital
300,000,000
Directors
Arvind Kanhaiyalal Agrawal
Cfo
about 2 years ago
about 2 years ago
Chandrakant Mohanlal Khetan
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Prabhakar Ramchandra Dalal
Director/Designated Partner
over 6 years ago
over 6 years ago
Ravi Purushottam Agrawal
Individual Promoter
over 6 years ago
over 6 years ago
Aayush Madhusudan Agrawal
Director/Designated Partner
over 6 years ago
over 6 years ago
Purushottam Bhagwandas Agrawal
Director
almost 8 years ago
almost 8 years ago
Gaurang Chinubhai Shah
Company Secretary
almost 12 years ago
almost 12 years ago
Rajesh Mannalal Agrawal
Director/Designated Partner
over 12 years ago
over 12 years ago
Madhusudan Bhagwandas Agrawal
Director/Designated Partner
over 15 years ago
over 15 years ago
Jainandra Kumar Rambaksha Tripathi
Person Incharge
about 19 years ago
about 19 years ago
Mannalal Bhagwandas Agrawal
Director
almost 46 years ago
almost 46 years ago
Past Directors
Anjana Grewal
Director
over 11 years ago
over 11 years ago
Viswanathan Hariharan Kalpati
Director
over 12 years ago
over 12 years ago
Manjiri Manohar Bhalerao
Nominee Director
over 17 years ago
over 17 years ago
Napoleon Chelliah
Company Secretary
almost 19 years ago
almost 19 years ago
Madhukar .
Director
over 19 years ago
over 19 years ago
Vikramaditya Raj Ugra
Nominee Director
over 20 years ago
over 20 years ago
Anil Bhubneshwar Kumar
Director
over 22 years ago
over 22 years ago
Yogesh Mannalal Agrawal
Whole Time Director
over 25 years ago
over 25 years ago
Patents
The present invention provides process for preparation of anti-inflammatory phytoconstituent derivatives derived from the gum resin of Boswellic serrata with ameliorated amounts of acetates of keto-beta-boswellic acid and less quantities of other boswellic acids and the incorporation of the same in oral dosage froms...
The present invention relates to a formulation comprising of carotenoids and micronutrients from carrots further supplemented with natural carotenoids along with vitamins and mineral to meet specific requirement of menopausel and post-menopausal women, and reduce the sumptoms and health risks during menopause and po...
The present invention relates to an improved and industrially advantageous process for the preparation Azelnidipine of formula (I) and its intermediates with higher yields and purity.
The present invention relates to an improved process for the preparation of Haprazole employing mixed solvent system in the condensation reaction resulting in Haprazole of high purity and better yield.
A process for the preparation of Besifloxacin hydrochloride formula-I comprising reaction of compound having Formula (II) with compound having Formula (III) in an organic solvent to produce a compound having Formula (IV). Halogenation of the compound of Formula (IV) followed by purification to obtain pure Besifloxac...
The present invention relates to an improved, commercially viable and industrially advantageous process for the preparation of Teneligliptin of formula (A) and acid addition salt thereof using a novel intermediate compound of formula (H).
A process for the preparation of Roflumilast formula-I comprising, preparation of anion of 4-amino-3, 5-dichloropyridine formula-Ill and in-situ reaction of anion of 4-amino-3, 5-dichloropyridine formula-Ill with activated compound of 3-cyclopropylmethoxy-4-difluromethoxybenzoic acid formula-V, followed by purificat...
The present invention relates to an improved and industrially advantageous process for the preparation luliconazole of formula (I) and its intermediates.
The present invention relates to an improved, commercially viable and industrially advantageous process for the preparation of difluprednate in higher yield and purity.
The present invention relates to an improved and industrially advantageous process for the preparation of-desonide sodium phosphate of formula (I).
The present invention relates to an improved, commercially viable and industrially advantageous process for the preparation of zucapsaicin using ethyl (6Z)-8-methylnon-6-enoyl carbonate.
The present invention relates to an improved and industrially advantageous process for the preparation Maraviroc of formula (I) and its intermediates.
This invention relates to a taste masked pharmaceutical composition in the form of rapidly dissolving film comprising Sildenafil or its isomers, enantiomers, pharmaceutically acceptable salts thereof and polyacrylic resin. The said film optionally contains one or more pharmaceutically acceptable excipients and is su...
This invention relates to a combination of dapoxetine and/or its isomers, enantioner s, pharmaceutically acceptable salts thereof and a compound belonging to the class of phosphodiesterase-V inhibitors and/or their isomers, enantiomers, pharmaceutically acceptable salts thereof; pharmaceutical compositions comprisin...
A composition containing Zolmitriptan in the form of oral disintegrating tablet for the acute treatment of migraines is disclosed. The said composition comprises (a) Zolmitriptan, a salt or solvate or polymorph thereof as active ingredient, (b) mannitoi, and (c) calcium silicate, and (d) optionally, one or more poly...
The present invention relates to once a day formulation of Antiprotozoal agent. More particularly the present invention relates to the controlled release once a day formulation of tinidazole for amoebiasis and giardiasis.
This invention relates to a pharmaceutical composition in the form of rapidly dissolving film comprising one or more water soluble polymers and tadalafil or its isomers, enantiomers, pharmaceutically acceptable salts thereof. The said film optionally contains one or more pharmaceutically acceptable excipients and is...
The present invention relates to extended release solid pharmaceutical composition comprising antihypertensives, in particular, Metoprolol succinate or pharmaceutically acceptable derivatives thereof and a process for preparing such a formulation.
A process for the preparation of lumefantrine without using Grignard reagent is disclosed. The process comprises condensation of 2,7-dichloro-9-(4-chlorobenzyliedne)fluorene-4-oxirane with N-dibutylamine in solvent free conditions, and isolation of pure lumefantrine using one or more organic solvents.
...
The present invention provides effervescent immediate release drug compositions comprising combination of artemether and lumefantrine, processes for their preparation; and methods of using such compositions to treat malaria.
5 SEP 2008
The present invention relates to controlled relase formulation of an antiviral drug acyclovir for twice a day dosing while increasing the gastric residence time by the use of osmotically controlled floating, bio-adhesive polymers and sewllable non-disintegrating tabltes.
The present invention relates to chewable solid pharmaceutical compositions comprising sildenafil citrate. Sildenafil citrate is a very bitter drug, hence the conventional tablets, comprise of a film coating for aesthetic appearance and acceptability. Chewable tablets are usually uncoated and hence there is a need t...
Lutein concentrate rich in micronutrients and is naturally bound form is prepared from lutein rich plant sources by an aqueous process. This unique product either in the paste or powder form and the blends thereof are incorporated in oral or topical pharmaceutical formulations for prevention or treatment of severa...
The present invention discloses natural composition for arthritis in oral dosage form with shelof life3 and stability and process for preparationthereof comprising herbal constituents for synergistic effect like commipphora mukul 25 mg to 500 mg, cedrus deodara 50 mg to 500 mg, Boerhaavia deiffusa 50 mg to 500 mg, Z...
The present invention describes formulation of phosphodiesterase inhibitors type V, administered in the patient in need of treatment Male Erectile Dysfunction (MED), prepared by complexation with a complexing agent for taste masking of the bitter agent with rapid effect for oral administration and process for prepar...
The present invention provides chewable immediate release drug compositions comprising combination of artemether and lumefantrine, processes for their preparation; and methods of using such compositions for the treatment of patients suffering from malaria.
A novel composition is disclosed of oral controlled release formulation of Amoxycillin for releasing the medicaments over a prolonged period of time suitable for once a day administration in highly absorptive regions of the gastrointestinal tract using dissolution controlled matrix technology.
The present invention provides compositions comprising novel extract of medicinal plant Phyllanthus emblica prepared using fresh fruits by totally aqueous technology comprising of blend of beneficial, health promoting constituents in a fairly concentrated form and process for preparation thereof. The present inventi...
The present invention relates to an improved and industrially advantageous process for the preparation efonidipine of formula (I) and its intermediates.
The present invention relates to an improved and industrially advantageous process for the preparation cilnidipine of formula (I) and its intermediates.
The present invention relates to a reliable and industrial applicable process for the preparation of crystalline Form II of 2-[3-Cyano-4-(2-methylpropoxy)phenyI]-4-methyl-5-thiazolecarboxyIic, commonly known as Febuxostat
Abstract
The present invention relates to an improved and industrially advantageous process for the preparation of Dabigatran Etexilate Mesylate of formula (I) and its intermediates.
The present invention relates to an improved and industrially advantageous process for preparation of Solifenacin of formula (I) or a succinate salt thereof of formula (II).
The present invention relates to an improved and industrially advantageous process for the preparation of Varenicline Tartrate of formula (I) and its intermediates.
The present invention relates to an improved and industrially advantageous process for preparation of Colesevelam Hydrochloride of formula (I).
The present invention provides an improved process for the preparation of highly pure Ursodiol through tert amine salt which minimizes formation of impurities.
Abstract
The present invention relates to an improved and industrially advantageous process for preparation of Cinacalcet base of formula (I) or a hydrochloride salt thereof of formula
(II).
The present invention relates to an improved and industrially advantageous process for the preparation of Ticagrelor of Formula (I).
The present invention provides an improved process for the preparation of highly pure Montelukast sodium through tert-butyl amine salt which minimizes formation of sulfoxide impurity.
The present invention provides an improved process for the preparation of highly pure Nepafenac going through amidation using ammonium chloride and DCC/HoBt as coupling agents minimizing impurities. The invention also relates to crystalline Form A obtained by the present invention and characterized by XRPD pattern c...
"BILASTINE SYNTHESIS PROCESS USING PHASE TRANSFER CATALYST"
The present disclosure concerns a process for preparing Bilastine using Phase Transfer Catalyst (PTC) providing an improved method which is commercially viable and industrially advantageous and yields bilastine in high purity and yield. The invention also ...
The present invention relates to delayed release pharmaceutical compositions comprising Prednisone using one or more rate controlling agent (s). Delayed release pharmaceutical compositions are provided having a core and a delayed release coating.
Specifically, the invention provides a delayed release oral dosage fo...
The present invention relates to aqueous compositions of Carrageenan its process for preparation and use of such composition for the treatment of inflammatory and other diseases.
Dated this: 16th day of July 2022
The present invention relates to stabilised pharmaceutical composition comprising Vildagliptin or its pharmaceutically acceptable salts thereof, its process for preparation and use of such a composition for the treatment of diabetes and other metabolic diseases.
ABSTRACT
"NOVEL COMPOSITION FOR THE TREATMENT OF HYPERTENSION"
The present invention relates to a novel composition comprising metoprolol, telmisartan and amlodipine or salts thereof for use in the treatment of hypertension. More specifically, the present invention relates to once-a-day delivery composition compri...
Registered Trademarks
[Class : 5] Medicinal And Pharmaceutical Preparations And Substances.
[Class : 5] Medicinal And Pharmaceutical Preparations And Substances.
[Class : 5] Medicinal And Pharmaceutical Preparations And Substances.
View +2945 more Brands for Ajanta Pharma Limited.
Charges
15 November 2006
Idbi Bank Limited
29 Crore
08 July 1997
State Bank Of India
100 Crore
03 July 1997
Sbm Bank (india) Limited
10 Crore
23 February 2007
Export Import Bank Of India
48 Crore
20 November 2003
Export Import Bank Of India
7 Crore
21 March 2013
State Bank Of Mauritius Limited
55 Crore
19 March 2012
Abu Dhabi Commercial Bank Ltd
55 Crore
07 January 2005
Export Import Bank Of India
1 Crore
11 March 2003
Export-import Bank Of India
67 Lak
13 November 2002
Export -import Bank Of India
4 Crore
17 January 2004
Export-import Bank Of India
5 Crore
26 May 2010
Export Import Bank Of India
11 Crore
28 August 2008
Export Import Bank Of India
15 Crore
11 March 2008
Export- Import Bank Of India
5 Crore
08 July 1997
State Bank Of India
32 Crore
29 October 2007
Export Import Bank Of India
14 Crore
29 August 2006
Export-import Bank Of India
15 Crore
24 December 2008
Export Import Bank Of India
17 Crore
18 November 2008
Canara Bank
15 Crore
12 December 2008
Canara Bank
23 Crore
21 January 2009
Idbi Bank Limited
23 Crore
07 January 2005
Export-import Bank Of India
7 Crore
10 July 2001
Industrial Development Bank Of India Limited
7 Crore
23 December 2002
Export-import Bank Of India
4 Crore
16 September 1998
Industrial Development Bank Of India Limited
7 Crore
17 September 1997
Industrial Development Bank Of India
10 Crore
10 August 2001
Export Import Bank Of India
2 Crore
13 June 2006
Export Import Bank Of India
7 Crore
15 January 2003
Punjab National Bank
7 Crore
08 November 2004
Export Import Bank Of India
5 Crore
01 February 2005
Export Emport Bank Of India
10 Crore
26 June 2001
Abu Dhabi Commercial Bank
0
11 February 2021
Rbl Bank Limited
10 Crore
26 June 2020
Citi Bank N.a.
35 Crore
20 November 2003
Export Import Bank Of India
0
03 July 1997
Others
0
17 September 1997
Industrial Development Bank Of India
0
16 September 1998
Industrial Development Bank Of India Limited
0
11 March 2003
Export-import Bank Of India
0
28 August 2008
Export Import Bank Of India
0
24 December 2008
Export Import Bank Of India
0
21 January 2009
Idbi Bank Limited
0
26 May 2010
Export Import Bank Of India
0
19 March 2012
Abu Dhabi Commercial Bank Ltd
0
21 March 2013
State Bank Of Mauritius Limited
0
26 June 2001
Abu Dhabi Commercial Bank
0
08 November 2004
Export Import Bank Of India
0
11 March 2008
Export- Import Bank Of India
0
29 August 2006
Export-import Bank Of India
0
15 November 2006
Idbi Bank Limited
0
23 February 2007
Export Import Bank Of India
0
01 February 2005
Export Emport Bank Of India
0
26 June 2020
Citi Bank N.a.
0
08 July 1997
State Bank Of India
0
23 December 2002
Export-import Bank Of India
0
17 January 2004
Export-import Bank Of India
0
13 June 2006
Export Import Bank Of India
0
18 November 2008
Canara Bank
0
13 November 2002
Export -import Bank Of India
0
29 October 2007
Export Import Bank Of India
0
10 July 2001
Industrial Development Bank Of India Limited
0
15 January 2003
Punjab National Bank
0
07 January 2005
Export-import Bank Of India
0
08 July 1997
State Bank Of India
0
07 January 2005
Export Import Bank Of India
0
10 August 2001
Export Import Bank Of India
0
12 December 2008
Canara Bank
0
11 February 2021
Others
0
20 November 2003
Export Import Bank Of India
0
03 July 1997
Others
0
17 September 1997
Industrial Development Bank Of India
0
16 September 1998
Industrial Development Bank Of India Limited
0
11 March 2003
Export-import Bank Of India
0
28 August 2008
Export Import Bank Of India
0
24 December 2008
Export Import Bank Of India
0
21 January 2009
Idbi Bank Limited
0
26 May 2010
Export Import Bank Of India
0
19 March 2012
Abu Dhabi Commercial Bank Ltd
0
21 March 2013
State Bank Of Mauritius Limited
0
26 June 2001
Abu Dhabi Commercial Bank
0
08 November 2004
Export Import Bank Of India
0
11 March 2008
Export- Import Bank Of India
0
29 August 2006
Export-import Bank Of India
0
15 November 2006
Idbi Bank Limited
0
23 February 2007
Export Import Bank Of India
0
01 February 2005
Export Emport Bank Of India
0
26 June 2020
Citi Bank N.a.
0
08 July 1997
State Bank Of India
0
23 December 2002
Export-import Bank Of India
0
17 January 2004
Export-import Bank Of India
0
13 June 2006
Export Import Bank Of India
0
18 November 2008
Canara Bank
0
13 November 2002
Export -import Bank Of India
0
29 October 2007
Export Import Bank Of India
0
10 July 2001
Industrial Development Bank Of India Limited
0
15 January 2003
Punjab National Bank
0
07 January 2005
Export-import Bank Of India
0
08 July 1997
State Bank Of India
0
07 January 2005
Export Import Bank Of India
0
10 August 2001
Export Import Bank Of India
0
12 December 2008
Canara Bank
0
11 February 2021
Others
0
